Xiaofeng Qian Selected Research

Xiaofeng Qian Research Topics

Disease

6	Neoplasms (Cancer) 10/2023 - 07/2017
6	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 08/2013
3	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2013
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2021
3	Reperfusion Injury 12/2018 - 01/2013
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020 - 08/2013
2	Chemical and Drug Induced Liver Injury 12/2014 - 07/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2013 - 06/2010
2	Fibrosis (Cirrhosis) 08/2013 - 06/2010
2	Ischemia 06/2012 - 06/2010
1	Bacterial Infections (Bacterial Infection) 04/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2020
1	Infections 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Pulmonary Embolism 07/2017
1	End Stage Liver Disease 07/2017
1	Acute Liver Failure (Fulminant Hepatic Failure) 03/2015
1	Tissue Adhesions 06/2014
1	Lymphatic Metastasis 09/2013
1	Liver Failure 09/2013
1	Necrosis 08/2013
1	Inflammation (Inflammations) 08/2013
1	Hepatitis 08/2013
1	Hemangioma (Angioma) 08/2013
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2013
1	Wounds and Injuries (Trauma) 06/2010
1	Brain Diseases (Brain Disorder) 01/2008

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2013
2	EnzymesIBA 01/2023 - 03/2015
2	camrelizumabIBA 01/2022 - 11/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2020
2	Proteins (Proteins, Gene)FDA Link 04/2021 - 01/2013
2	Sorafenib (BAY 43-9006)FDA Link 07/2017 - 09/2013
2	Interleukin-17 (Interleukin 17)IBA 08/2013 - 01/2013
2	CytokinesIBA 08/2013 - 06/2012
1	Diacylglycerol KinaseIBA 10/2023
1	Ubiquitin-Specific ProteasesIBA 10/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	Orosomucoid (Seromucoid)IBA 01/2023
1	thymidine kinase 1IBA 01/2023
1	apatinibIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	sintilimabIBA 01/2022
1	anlotinibIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	ChitinasesIBA 04/2021
1	HydrolasesIBA 04/2021
1	NivolumabIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2020
1	Gemcitabine FDA Link 11/2020
1	Circular RNAIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 11/2016
1	3' Untranslated Regions (3' UTR)IBA 11/2016
1	Transcription Factor CHOPIBA 03/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2015
1	Capsules (Microcapsules)IBA 12/2014
1	Ethanol (Ethyl Alcohol)IBA 12/2014
1	wuzhiIBA 12/2014
1	Carbon Tetrachloride (Tetrachloromethane)IBA 08/2013
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 08/2013
1	Tacrolimus (Prograf)FDA LinkGeneric 07/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2013
1	NF-kappa B (NF-kB)IBA 04/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2013
1	LipopolysaccharidesIBA 01/2013
1	Alanine Transaminase (SGPT)IBA 06/2010
1	Hydroxyproline (4 Hydroxyproline)IBA 06/2010
1	BilirubinIBA 06/2010
1	Laminin (Merosin)IBA 06/2010
1	AlbuminsIBA 06/2010
1	Hyaluronic Acid (Hyaluronan)IBA 06/2010
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2010
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2010

Therapy/Procedure

3	Liver Transplantation 07/2017 - 06/2010
2	Therapeutics 10/2023 - 01/2008
2	Hepatectomy 12/2018 - 08/2013
1	Metastasectomy 01/2023
1	Aftercare (After-Treatment) 01/2022
1	Perioperative Period 01/2022
1	Neoadjuvant Therapy 01/2022
1	Immunotherapy 01/2021
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2014
1	Transplantation 06/2014